Navigation Links
Wound Management Technologies, Inc. Announces Clarification of Eprint Viewing of Case Report in Advances in Skin and Wound Journal

FORT WORTH, Texas, Aug. 13 /PRNewswire-FirstCall/ -- Wound Care Innovations, LLC, a subsidiary of Wound Management Technologies, Inc., (OTC Bulletin Board: WNDM), is excited about expanding upon the announcement that was made on Tuesday regarding the publication of (2) independent case reports utilizing their advanced wound care collagen product, CellerateRx(R), in the August edition of Advances in Skin and Wound Care. The case presentations were on recalcitrant diabetic wounds. The article will be available in its entirety for viewing on the company website, in two weeks. In the meantime, the abstract may be viewed by going to, click current issue (top left corner), then scroll down to article 370 "Activated, Type I Collagen (CellerateRx) and Its Effectiveness in Healing Recalcitrant Diabetic Wounds: A Case Presentation" and click abstract.

"We are excited about providing additional data regarding the cases that have successfully identified CellerateRx(R) as a very strong product in the management of diabetic wounds. We are also very excited about being able to provide eprints of the article on our site in the near term to enable our shareholders and customers to have the most up-to-date information on CellerateRx(R)," states Cathy Bradshaw, President of Wound Care Innovations, LLC.

Please feel free to contact us with any additional questions on the product or the development of our Company.

About Wound Management Technologies, Inc.:

Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM), with its corporate headquarters in Fort Worth, Texas, markets and distributes wound care products to the healthcare market under patented technology licensed to the Company. The Company is positioned and seeks to be a leading provider of wound care products. For more information on the Company please visit the Company's Website at

"Safe Harbor" Statement: Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development are "forward-looking statements," within the meaning of the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. This document may contain forward-looking statements concerning the Company's operations, current and future performance and financial condition. These items involve risks and uncertainties such as product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, the ability to consummate and integrate acquisitions, and other risks and uncertainties detailed in the Company's SEC filings. The Company undertakes no obligation to revise any of these statements to reflect the future circumstances or the occurrence of unanticipated events.

Product Information Shareholder Relations

Cathy Bradshaw Lucy Singleton

President Secretary

954-315-9242 817-820-7080

SOURCE Wound Management Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Wound Management Technologies, Inc. Announces Products to Be Registered in Taiwan
2. Michael and Terry Ward Donate $1 Million to Wounded Warrior Project (WWP)
3. Canica Design Awarded Milestone U.S. Patent for Dynamic Wound Closure Systems
4. Wound Management Technologies, Inc. Announces Filing of a 510K
5. ETHICON Receives Offer from One Equity Partners to Purchase Professional Wound Care Business
6. The Wound Institute(R) Launches Educational Course on Chronic Wound Infections
7. Wound Management Technologies, Inc. Announces Sales Agreement with EWA Government Systems, Inc.
8. Freedom Celebration - Gibson Guitar to Provide Instruments for the Wounded
9. National Rehabilitation Hospital Team to Work with US Army to Improve Rehab Care for Wounded Soldiers
10. Wound Care Education Institute to Partner with Wisconsin Organizations to Improve Pressure Ulcer Care
11. Antibiotics can prevent wound complications of childbirth, Stanford/Packard study finds
Post Your Comments:
(Date:12/1/2015)... ... ... Growth in medical payments per workers’ compensation claim in Louisiana slowed from 2011 ... according to a recent study by the Workers Compensation Research Institute (WCRI). , ... per claim with more than seven days of lost time continued to be higher ...
(Date:12/1/2015)... Wayland, MA (PRWEB) , ... December 01, 2015 , ... ... adults has a tattoo — a number even greater among Millennials (a whopping one ... there are more and more people who are dissatisfied with their ink. In fact, ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... technicians must mark the film for accurate interpretation by the radiologist. The marking ... an inventor from Sacramento, Calif., has found a way to alleviate this problem. ...
(Date:12/1/2015)... ... 01, 2015 , ... Next IT Healthcare, the leader in ... this year’s Fierce Innovation Awards: Healthcare Edition, an awards program from the publisher ... in the category of Digital Solutions for its innovative, industry-leading product, Alme Health ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Effective Post-Affiliation Integration ,” addresses a main “pain point” for merging or aligning ... results, once a deal is signed. This quick-read guidance suggests that failing ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , Dec. 1, 2015 Relmada Therapeutics, Inc. ... treatment of chronic pain, announced today that the company will ... be held December 1-3 at the Luxe Sunset Boulevard Hotel ... Traversa , CEO of Relmada Therapeutics, will present on Thursday, ... Time). . Please register at least 10 ...
(Date:12/1/2015)... 2015 CytRx Corporation (NASDAQ: CYTR ), ... today announced that it has reached its enrollment target ... 3 clinical trial of aldoxorubicin in patients with previously ... be completed in Q1 2016. The Phase 3 trial is ... Protocol Assessment from the FDA at 79 sites in ...
(Date:12/1/2015)... , Dec. 1, 2015  Today, ... the launch of CareFront, a first-of-its-kind population health ... diagnosed with cancer. Designed to be built into ... cancer patients with resources for their care and ... program also offers tools to help patients understand ...
Breaking Medicine Technology: